Online
Natco Pharma
BSE: 524816 | NSE: NATCOPHARM | ISIN: INE987B01018 | Pharmaceuticals
Natco Pharma Q3 net profit at Rs 12.1 cr
Natco Pharma has announced its third quarter results. The company's net sales were at Rs 116.7 crore versus Rs 89.66 crore. Its net profit was at Rs 1...
28-01-2009
24-11-2008: Buy Natco Pharma: LKP Shares
01-07-2008: Natco Pharma Q4 FY08 profit at Rs 12.2 cr
27-10-2006: Natco Pharma Q2 net up at Rs 9.76cr
30-01-2006: Natco Pharma Q3 net profit up at Rs 5.25cr
Natco Pharma
LKP Shares has recommended a buy rating on Natco Pharma. Natco trading at half its book value has robust EBIDTA margins of 22% and the research firm i...
24-11-2008
Cipla has target of Rs 350-360: Anu Jain
Cipla has target of Rs 350-360, says Anu Jain, Vice President-IIFL Private Wealth Management at India Infoline....
23-11-2009
19-11-2009: Buy Cipla, says Sudarshan Sukhani
19-11-2009: Sudarshan Sukhani's top 5 picks for today's trade
19-11-2009: Buy Ranbaxy Laboratories: Sukhani
17-11-2009: Cipla has target of Rs 320: Mohindar
Peers
Buy Sun Pharma; target of Rs 1485: India Infoline
India Infoline is bullish on Sun Pharma and has recommended buy rating on the stock with a target of Rs 1485, in its November 12, 2009 research report...
13-11-2009
10-11-2009: Buy Cipla, target of Rs 370: Hem Securities
06-11-2009: Sun Pharma underperformer, target Rs 1355: Karvy
04-11-2009: Hold Cipla, target Rs 335: KRChoksey
30-10-2009: Hold Sun Pharma; target of Rs 1422: Sharekhan
30-10-2009: NATCO Q2 up
26-10-2009: Mkts end lower on sell off in IT, realty, bankingMonday, October 26, 2009,10:20 [IST]
21-10-2009: Retail sale of Tamiflu limited
20-10-2009: Mkts end negative; Sensex down by 100 ptsTuesday, October 20, 2009,10:08 [IST]
20-10-2009: Sensex volatile; Tata Power, L&T dipTuesday, October 20, 2009,10:08 [IST]
16-10-2009: Nearly 3,000 Tamiflu tablets sold in 24 days
26-09-2009: Watch/Listen: Mint in multimedia- 26 September
26-09-2009: Natco capsules for swine flu
25-09-2009: NATCO launches NATFLU capsules for H1N1
25-09-2009: The Mint report for 25 September 2009
25-09-2009: Nine die of swine flu, 283 fresh cases in the country
25-09-2009: 1.25 mn capsules of new swine flu drug enter Indian market
25-09-2009: 1.25 mn capsules of new swine flu drug enter Indian market
25-09-2009: 1.25 mn capsules of new swine flu drug enter Indian market
25-09-2009: Strides Arco to sell generic Tamiflu in pharmacies
25-09-2009: Nine die of swine flu, 283 fresh cases in the country
23-09-2009: Nifty closes above 5K after 16 monthsTuesday, September 22, 2009,10:32 [IST]
23-09-2009: High-on-hype Tamiflu may be low on margins
23-09-2009: Pharma : Natco plans paediatric version of Tamiflu
22-09-2009: Market opens at choppy Sensex; BPCL, IOC gainTuesday, September 22, 2009,10:32 [IST]
19-11-2009: Sensex sheds 213 points on profit booking
18-11-2009: Sensex breaks the 3-day winning streak
18-11-2009: Sensex ends marginally lower; SBI, ICICI dipWednesday, November 18, 2009,10:24 [IST]
18-11-2009: Sun Pharma gets us nod for lukaemia drug
23-11-2009: Nifty hovers near 5100; RIL, ITC, HCL Tech up
21-11-2009: Sensex ends in positive; banks, metal gainFriday, November 20, 2009,10:21 [IST]
19-11-2009: Nifty ends below 5k mark; metal, telecom dipThursday, November 19, 2009,10:16 [IST]
19-11-2009: Nifty trading with negative bias; HCL, Unitech dipThursday, November 19, 2009,10:16 [IST]
16-11-2009: India Inc gets into bear hug with Russian consumers
14-11-2009: India Inc gets into bear hug with Russian consumers
03-11-2009: EU seizes another generic package
23-10-2009: Dr.Reddy's Lab net profit rises 116.52 percent
19-11-2009: Nifty ends below 5k mark; metal, telecom dipThursday, November 19, 2009,10:16 [IST]
19-11-2009: Nifty trading with negative bias; HCL, Unitech dipThursday, November 19, 2009,10:16 [IST]
14-11-2009: Bulls push Sensex up 4.2 percent
14-11-2009: Bulls push Sensex up 4.2 percent
23-11-2009: Breaking an unholy alliance
21-11-2009: Did U.S. make mistake in skipping vaccine additive?
21-11-2009: Canada to have vaccine soon for half population
20-11-2009: Glaxo, Merck developing drugs for kala azar
